Contract facts
FederalNo full NAICS 541380 intel page yet. Browse NAICS intelligence
DECREMENT UNEXPENDED FUNDING/VALUE FROM LEGACY STORAGE AND SHIPMENT ORDER WITH FISHER FOR R&D VACCINE DEVELOPMENT PRODUCTS is a federal award for W6qk Acc-Apg held by Fisher Bioservices Inc. Estimated value $2.2M ($-58,710.36 obligated). Current period of performance ends Mar 7, 2022. Last award drew 1 bidder. Place of performance: ROCKVILLE MD.
DECREMENT UNEXPENDED FUNDING/VALUE FROM LEGACY STORAGE AND SHIPMENT ORDER WITH FISHER FOR R&D VACCINE DEVELOPMENT PRODUCTS
Recompete timing
PublicCurrent PoP ended Mar 7, 2022 (1669 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W911QY17F0028? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordFisher Bioservices Inc — $101.3M obligated across 96 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W911QY17F0028?
W911QY17F0028 (Decrement unexpended funding VALUE FROM LEGACY) is a W6qk Acc-Apg award with a potential value of $2.2M, currently held by Fisher Bioservices Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W911QY-17-F-0028?
W911QY-17-F-0028 is the dashed form of PIID W911QY17F0028 (Decrement unexpended funding VALUE FROM LEGACY), held by Fisher Bioservices Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W911QY17F0028?
W6qk Acc-Apg awarded W911QY17F0028 to Fisher Bioservices Inc (potential $2.2M).
Who is the incumbent on W911QY17F0028?
Fisher Bioservices Inc is the incumbent with $101.3M across 96 related awards in SCOUT’s public footprint. The current period of performance ends Mar 7, 2022.
When does Fisher Bioservices Inc’s W911QY17F0028 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 7, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W911QY17F0028? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.